Coronary Artery Disease Clinical Trials in Boston, Massachusetts
16 studies are recruiting for coronary artery disease in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Product Surveillance Registry
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…
- Stage
- Not phased
- Ages
- Any age
- Site
- Research site, Boston, Massachusetts
- Locations
- 401 in total
- Run by
- Medtronic
-
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibility of the percutaneous endovascular catheter-facilitated intramyocardial delivery of XC001 in patients with RA due to obstructive CAD. Pa…
- Stage
- Phase 2
- Ages
- 18 to 85
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Locations
- 14 in total
- Run by
- XyloCor Therapeutics, Inc.
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an o…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Locations
- 18 in total
- Run by
- Weill Medical College of Cornell University
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
This is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Locations
- 18 in total
- Run by
- Weill Medical College of Cornell University
-
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
The OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current standard of care (IVUS-…
- Stage
- Not phased
- Ages
- 18 to 85
- Site
- Bringham and Women's Hospital, Boston, Massachusetts
- Locations
- 14 in total
- Run by
- Fundación EPIC
-
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…
- Stage
- Not phased
- Ages
- Any age
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Locations
- 48 in total
- Run by
- Minneapolis Heart Institute Foundation
-
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
The purpose of the study is to assess the safety and efficacy of the Orsiro® Mission 48- mm Sirolimus-Eluting Coronary Stent System in the treatment of subjects with atherosclerotic lesion(s) >36 mm and ≤ 44 mm in length (by visual estimate) in the native coronary arteries with a reference vessel d…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Locations
- 23 in total
- Run by
- Teleflex
-
SELUTION 4 De Novo Small Vessel IDE Trial
Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Beth Israel Deaconess, Boston, Massachusetts
- Locations
- 70 in total
- Run by
- M.A. Med Alliance S.A.
-
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
The primary objective of this protocol is to develop a comprehensive, multicenter international prospective registry to capture long-term clinical outcomes for adult patients undergoing percutaneous coronary intervention (PCI) with drug-coated balloons (DCB) for de novo coronary artery disease.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Tufts Medical Center, Boston, Massachusetts
- Locations
- 19 in total
- Run by
- Emory University
-
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
Traditionally, the severity of a blockage (stenosis) in a coronary artery has been determined by visual angiographic assessment of the diameter of the artery at the level of a blockage compared to a normal healthy area of the same artery. With the advent of invasive physiological testing to assess …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Run by
- Beth Israel Deaconess Medical Center
-
CTSN Embolic Protection Trial
This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.
- Stage
- Not phased
- Ages
- 60 and older
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Locations
- 28 in total
- Run by
- Icahn School of Medicine at Mount Sinai
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
The goal of this clinical trial is to evaluate whether disclosure of a polygenic risk score for coronary artery disease (CAD PRS) influences cardiovascular health and risk factor modification over one year among adults aged 30-75 years in the Mass General Brigham primary care network who are not cu…
- Stage
- Not phased
- Ages
- 30 to 75
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Run by
- Massachusetts General Hospital
-
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intel…
- Stage
- Not phased
- Ages
- 40 to 75
- Site
- Brigham and Women's Hospital, Boston, Massachusetts
- Run by
- Brigham and Women's Hospital
-
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…
- Stage
- Not phased
- Ages
- Any age
- Site
- Tufts Medical, Boston, Massachusetts
- Locations
- 72 in total
- Run by
- University of British Columbia
-
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.
- Stage
- Not phased
- Ages
- 18 to 90
- Site
- Massachusetts General Hospital, Boston, Massachusetts
- Locations
- 18 in total
- Run by
- Kardion Inc
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
A Prospective, Multicenter, Randomized, Two-Arm, Single-blind Superiority Trial to Evaluate the Safety and Efficacy of the MagicTouch™ Sirolimus- Coated Balloon in the Treatment of Coronary Drug-Eluting Stent In-Stent Restenosis. Subjects with prior DES implantation presenting with ISR lesions unde…
- Stage
- Not phased
- Ages
- 18 to 110
- Site
- Beth Israel Deaconess Medical Center, Boston, Massachusetts
- Locations
- 28 in total
- Run by
- Concept Medical Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.